抗抑郁药氟西汀的临床新用途被引量：2

暂未订购

导出

摘要氟西汀是第一个应用于临床的 SSRI类抗抑郁剂 ,应用中发现除了抗抑郁作用外 ,氟西汀还具有治疗头痛、肥胖、早泄、进食障碍、惊恐障碍、儿童孤独症等多种疾病的作用。

作者黄流清黄继忠

机构地区上海长征医院神经科上海市精神卫生中心

出处《国外医学（精神病学分册）》 2002年第1期28-31,共4页 Foreign Medical Sciences(Section of Psychiatry)

关键词氟西汀抗抑郁药五羟色胺偏头痛进食障碍惊恐障碍肥胖早泄儿童孤独症

参考文献21

1Rocco JW, Sidrandky D. P16(Mtsl/cdkn2/ink4a) in cancer progression. Exp Cell Res, 2001,64(1): 42-45.
2Serrano M. INK4a/ARF locus in murine tumorigenesis. Carcinogenesis, 2000, 21(10): 865-869.
3Kamb A, Gruis NA, Wearver-Feldhaus J, et al. Acell cycle regulator potentially involved in genesis of many tumor typos. Science, 1994, 264(15): 436-440.
4Liggett WH, Sidransky D. Role of the p16 tumor suppressor gent in cancer. J Clin Oncol, 1998, 16(13): 1197-1206.
5Asp J, Inerot S, Block JA, et al. Alterations in the regulatory pathyway involving p16, pRB and cdk4 in human tumor. J Orthop Res, 2001, 19(1): 149-154
6Ruas M, Peters G. The p16 INk4a/CDKN2a tumor suppressor and its relative. Biochem Biophys Acta, 1998, 14(2): 115-177.
7Ivanchuk SM, Mondal S, Dirks, PB, et al. The INK4A/ARF locus: role in cell, cycle control and apoptosis and implications for glioma growth. J Neurooncol, 2001, 51(3): 219-229.
8Nielsen NH, Roos G, Emdin SO, et al. Methylation of the P16(Ink4a) tumor suppressor gene cpg island in breast Cancer Lett, 2001, 163(1):59-69.
9Sharps P, Bonetta J. Molecular genetic correlates of p16, cdk4 and pRB immunohistochemistryin glioblastoma. J Neuropathol Exp Neurol, 1999, 58(2): 122-130.
10Woloschak M, Yu A, Xiao J, et al. Frequent loss of the p16 INK4a gene product in human pituitary tumors. Cancer Res, 1996, 56(11): 2493-2496.

1杨海晨,高欢,余常红.西酞普兰治疗惊恐障碍对照研究[J].山东精神医学,2006,19(3):186-187. 被引量：4
2栗克清,崔泽,崔利军,江琴普,武浩然,张武文,黄敬,靳建勋,王学义,徐建国,陶钧,张彦平,张本,张玉夫,侯海山,耿建萍,赵恩义,石光.河北省精神障碍的现况调查[J].中华精神科杂志,2007,40(1):36-40. 被引量：133
3张帕芳.黛安神治疗神经症临床疗效观察[J].中国神经精神疾病杂志,2000,26(2):77-77.
4American Psychiatry Association. Panic Disorder Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition[M]. Psychiatry Association American. Washington D C, 1994 .397-403.
5郝伟.精神科疾病临床诊疗规范教程[J].北京:北京大学出版社.2009:336-338.
6Kloin E, Colin V, Stalk J. et al. Alprazolam withdrawal in Ptients with panic disorder and generalized anxiety disorder: vulnerabihty and effect of carbamazepine[J]. Am J Psychiatry, 1994 (5) :1760- 1766.
7TA JMA O. Recent trends in phamacotherapy for anxiety disorders[J].Nihou Shinkei Seishin Yakurigaku Zasshi, 2004,24 (3): 133- 136.
8韩彦超,栗克清,崔利军,江琴普,崔泽,孙秀丽,高良会.河北省惊恐障碍的现况调查[J].中华流行病学杂志,2007,28(9):837-837. 被引量：5
9陆志城.2001年美国药品市场回顾[J].医药经济信息,2002,(14):24-26.
10王泽民.浅谈人世后国内抗抑郁药生产企业的发展趋势[J].医药经济信息,2002,(12):11-11.

国外医学（精神病学分册）

2002年第1期

内容加载中请稍等...